Lee HC - Search Results

1

Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone.

Park SE, Kang ES, Kim DH, Kim SK, Lee JH, Ahn CW, Lee HC, Cha BS. Park SE, et al. Among authors: lee hc, lee jh. Diabet Med. 2009 Jun;26(6):577-81. doi: 10.1111/j.1464-5491.2009.02728.x. Diabet Med. 2009. PMID: 19538231

2

Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patients.

Kim DJ, Kim YM, Yun YS, Ahn CW, Cha BS, Song YD, Lim SK, Kim KR, Hahn JS, Huh KB, Lee HC. Kim DJ, et al. Among authors: lee hc. Diabet Med. 2003 Aug;20(8):661-4. doi: 10.1046/j.1464-5491.2003.01012.x. Diabet Med. 2003. PMID: 12873295

3

Insulin sensitivity in physically fit and unfit children of parents with Type 2 diabetes.

Ahn CW, Song YD, Nam JH, Kim DM, Woo SO, Park SW, Cha BS, Lim SK, Kim KR, Lee JH, Lee HC, Huh KB. Ahn CW, et al. Among authors: lee hc, lee jh. Diabet Med. 2004 Jan;21(1):59-63. doi: 10.1046/j.1464-5491.2003.01049.x. Diabet Med. 2004. PMID: 14706055

4

The effect of rosiglitazone on insulin sensitivity and mid-thigh low-density muscle in patients with Type 2 diabetes.

Nam JS, Nam JY, Yoo JS, Cho M, Park JS, Ahn CW, Cha BS, Lee EJ, Lim SK, Kim KR, Lee HC. Nam JS, et al. Among authors: lee ej, lee hc. Diabet Med. 2010 Jan;27(1):30-6. doi: 10.1111/j.1464-5491.2009.02897.x. Diabet Med. 2010. PMID: 20121886

5

Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.

Won HK, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Won HK, et al. Among authors: lee bw, lee hc. Diabet Med. 2012 Jan;29(1):74-9. doi: 10.1111/j.1464-5491.2011.03386.x. Diabet Med. 2012. PMID: 21781151

6

Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.

Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Nam SY, et al. Among authors: lee hc. Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7. doi: 10.1038/sj.ijo.0801636. Int J Obes Relat Metab Disord. 2001. PMID: 11477493 Clinical Trial.

7

Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients.

Ahn CW, Kim HS, Nam JH, Song YD, Lim SK, Kim KR, Lee HC, Huh KB. Ahn CW, et al. Among authors: lee hc. Diabet Med. 2002 Mar;19(3):227-33. doi: 10.1046/j.1464-5491.2002.00670.x. Diabet Med. 2002. PMID: 11918625

8

A case of primary antiphospholipid syndrome and Type 2 diabetes mellitus with large artery thromboses successfully treated by abdominal stent implantation.

Kim CS, Kim DM, Park JS, Nam JY, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC. Kim CS, et al. Among authors: lee hc. Diabet Med. 2004 Nov;21(11):1258-9. doi: 10.1111/j.1464-5491.2004.01347.x. Diabet Med. 2004. PMID: 15498097 No abstract available.

9

Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats.

Kim HJ, Zhao ZS, Lee YJ, Shim WS, Kim SK, Ahn CW, Park CW, Lee HC, Cha BS. Kim HJ, et al. Among authors: lee hc, lee yj. Diabetes Obes Metab. 2006 Mar;8(2):175-83. doi: 10.1111/j.1463-1326.2005.00482.x. Diabetes Obes Metab. 2006. PMID: 16448521

10

A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion.

Kim I, Kang ES, Yim YS, Ko SJ, Jeong SH, Rim JH, Kim YS, Ahn CW, Cha BS, Lee HC, Kim CH. Kim I, et al. Among authors: lee hc. Pharmacogenomics J. 2011 Jun;11(3):191-8. doi: 10.1038/tpj.2010.22. Epub 2010 Mar 30. Pharmacogenomics J. 2011. PMID: 20351753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,925 results

Search Page

Filters